Tempus AI Inc
Tempus AI Inc (TEM) Options Open Interest
TEM options open interest is 463,509 contracts. The 2-week average daily volume is 40,548 contracts across the chain.
Read more
Monitoring TEM open interest helps you see where real money is positioned on Tempus AI Inc's options and which strikes are attracting the most commitment from traders. Tempus AI Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor TEM options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising TEM options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Tempus AI Inc to settle.
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies.
In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where TEM open interest is concentrated. Our scanner maps Tempus AI Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Tempus AI Inc's options open interest as the signal it is, not as an afterthought.
| 100.00 | 0.04 | 0.10 | 0.07 | 92% | +0.0212 | 1,957 |
| 90.00 | 0.37 | 0.48 | 0.43 | 85% | +0.1070 | 946 |
| 67.00 | 10.05 | 12.10 | 11.08 | 75% | +0.9437 | 847 |
| 70.00 | 7.60 | 9.85 | 8.73 | 89% | +0.8351 | 733 |
| 75.00 | 3.50 | 5.75 | 4.63 | 74% | +0.6694 | 484 |
| 40.00 | — | 0.55 | 0.55 | 322% | -0.0361 | 2,413 |
| 52.00 | — | 0.14 | 0.14 | 161% | -0.0214 | 2,085 |
| 78.00 | 3.00 | 3.35 | 3.18 | 77% | -0.4854 | 1,037 |
| 70.00 | 0.26 | 0.58 | 0.42 | 71% | -0.1149 | 684 |
| 59.00 | — | 0.30 | 0.30 | 136% | -0.0488 | 389 |
As of September 18, 2026
Follow the money
Track TEM open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→